Amgen Inc. Common Stock (AMGN)

About AMGN

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEV…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

31,500

Website

www.amgen.com/

Fundamentals

1-day range

$431.01$442.13

Market cap

$218.50B

P/E (trailing)

25.84

P/E (forward)

17.91

EPS (trailing)

$16.10

Dividend yield

3.21%

Beta

0.42

Avg. volume

2.71M

Ex-dividend date

August 21, 2026

Dividend pay date

September 11, 2026

Forecasts

29 analyst ratings

Amgen Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• AMGN

  Amgen Inc. Common Stock

  $432.42

  ▼ 1.05%
  Market cap $218.50BP/E 25.84
  $269.77$447.03
• ARGX

  argenx SE American Depositary Shares

  $1,025

  ▼ 3.22%
  Market cap $54.32BP/E 22.19
  $568.4$913
• RVMD

  Revolution Medicines Inc. Common Stock

  $207.89

  ▼ 6.00%
  Market cap $42.05BP/E —
  $35.64$224.31
• BNTX

  BioNTech SE American Depositary Share

  $102.04

  ▼ 8.40%
  Market cap $22.91BP/E —
  $79.52$124
• MRNA

  Moderna Inc. Common Stock

  $137.93

  ▼ 3.39%
  Market cap $21.50BP/E —
  $22.28$176.66
• NBIX

  Neurocrine Biosciences Inc. Common Stock

  $153.98

  ▼ 1.24%
  Market cap $16.25BP/E 22.33
  $122.14$186.12
• HALO

  Halozyme Therapeutics Inc. Common Stock

  $105.33

  ▼ 1.49%
  Market cap $10.17BP/E 27.63
  $61.23$109.66

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Lilly's Multiple Assumes Less Growth Than You Think
  Yahoo · 8/21/2026
• Why the Dow Is Beating the Nasdaq Again
  Yahoo · 8/21/2026
• Making Drugs With AI: Biopharma Giants Gear Up For New Arena
  Yahoo · 8/21/2026
• Amgen (AMGN) Gets A Fresh Target, Is It Fully Priced?
  Yahoo · 8/21/2026
• SCHD: We Were Horribly Wrong
  SeekingAlpha · 8/21/2026
• Which dow jones stocks are moving on Thursday?
  ChartMill · 8/20/2026
• Discover which dow jones stocks are making waves on Thursday.
  ChartMill · 8/20/2026
• Global DLL3 Targeted Therapies Market 2026-2030: Profiles Amgen, Zai Lab, Boehringer Ingelheim and Phanes Therapeutics
  Yahoo · 8/20/2026

• Rachna Khosla · August 13, 2026 · Option Exercise

  1.3K @ $162.6
• Rachna Khosla · August 13, 2026 · Sale

  1.3K @ $416.43
• Rachna Khosla · August 11, 2026 · Sale

  2.0K @ $412.57
• Matthew C. Busch · August 7, 2026 · Grant

  730
• Michael Drake V · August 7, 2026 · Grant

  64
• Omar Ishrak · August 7, 2026 · Grant

  85
• Charles M. Holley · August 7, 2026 · Grant

  103
• Derek Miller · August 6, 2026 · Option Exercise

  1.8K @ $177.46
• Derek Miller · August 6, 2026 · Option Exercise

  2.1K @ $162.6
• Derek Miller · August 6, 2026 · Sale

  1.8K @ $402.54
• Derek Miller · August 6, 2026 · Sale

  2.1K @ $402.54
• Nancy A. Grygiel · August 6, 2026 · Option Exercise

  1.0K @ $177.31
• Nancy A. Grygiel · August 6, 2026 · Option Exercise

  2.0K @ $177.46
• Nancy A. Grygiel · August 6, 2026 · Sale

  1.0K @ $402.16
• Nancy A. Grygiel · August 6, 2026 · Sale

  2.0K @ $402.16

Institutional Ownership

March 31, 2026

Total shares held

408.43M

Total value held

$140.14B

Institutional holders

3107